Joop S.E. Laven

38.7k total citations · 12 hit papers
352 papers, 20.8k citations indexed

About

Joop S.E. Laven is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Joop S.E. Laven has authored 352 papers receiving a total of 20.8k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Reproductive Medicine, 192 papers in Public Health, Environmental and Occupational Health and 96 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Joop S.E. Laven's work include Ovarian function and disorders (189 papers), Reproductive Biology and Fertility (153 papers) and Ovarian cancer diagnosis and treatment (50 papers). Joop S.E. Laven is often cited by papers focused on Ovarian function and disorders (189 papers), Reproductive Biology and Fertility (153 papers) and Ovarian cancer diagnosis and treatment (50 papers). Joop S.E. Laven collaborates with scholars based in Netherlands, United States and United Kingdom. Joop S.E. Laven's co-authors include Bart C.J.M. Fauser, Axel P. N. Themmen, Frank H. de Jong, Helena Teede, Jenny A. Visser, Richard S. Legro, Robert J. Norman, Didier Dewailly, Marinus J.C. Eijkemans and Régine P.M. Steegers‐Theunissen and has published in prestigious journals such as JAMA, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Joop S.E. Laven

341 papers receiving 20.2k citations

Hit Papers

Recommendations from the ... 2002 2026 2010 2018 2018 2011 2016 2003 2015 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome
    2018 1.5k citations Helena Teede, Marie Misso et al. profile →
  2. Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
    2011 1.5k citations Bart C.J.M. Fauser, Richard S. Legro et al. Fertility and Sterility profile →
  3. Polycystic ovary syndrome
    2016 1.2k citations Ricardo Azziz, Andrea Dunaif et al. profile →
  4. Ultrasound assessment of the polycystic ovary: international consensus definitions
    2003 738 citations Joop S.E. Laven, Didier Dewailly et al. Human Reproduction Update profile →
  5. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome
    2015 721 citations Sharon E. Oberfield, Joop S.E. Laven et al. profile →
  6. Antimüllerian hormone serum levels: a putative marker for ovarian aging
    2002 705 citations Joop S.E. Laven, Frank H. de Jong et al. Fertility and Sterility profile →
  7. Anti-Mullerian hormone: a new marker for ovarian function
    2005 617 citations Jenny A. Visser, Frank H. de Jong et al. profile →
  8. Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality
    2016 499 citations Taulant Muka, Joop S.E. Laven et al. profile →
  9. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications
    2014 455 citations Frank J. Broekmans, Joop S.E. Laven et al. Human Reproduction Update profile →
  10. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society
    2013 364 citations Didier Dewailly, Marla E. Lujan et al. Human Reproduction Update profile →
  11. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis
    2020 258 citations Joop S.E. Laven, Annemieke Hoek et al. Human Reproduction Update profile →
  12. Polycystic ovary syndrome
    2024 137 citations Helena Teede, Robert J. Norman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joop S.E. Laven Netherlands 67 14.6k 11.5k 3.3k 2.9k 2.5k 352 20.8k
Stephen Franks United Kingdom 76 18.0k 1.2× 13.8k 1.2× 2.4k 0.7× 4.6k 1.6× 2.9k 1.1× 286 23.3k
Bart C.J.M. Fauser Netherlands 83 19.8k 1.4× 16.2k 1.4× 6.2k 1.8× 2.9k 1.0× 2.7k 1.1× 299 26.1k
Richard S. Legro United States 79 23.8k 1.6× 16.1k 1.4× 3.0k 0.9× 6.0k 2.1× 3.1k 1.2× 385 30.3k
Ricardo Azziz United States 82 22.3k 1.5× 14.1k 1.2× 1.9k 0.6× 8.3k 2.9× 6.0k 2.4× 389 30.6k
Andrea Dunaif United States 71 20.1k 1.4× 13.1k 1.1× 1.7k 0.5× 6.3k 2.2× 3.1k 1.2× 190 25.5k
Héctor F. Escobar‐Morreale Spain 63 12.3k 0.8× 7.4k 0.7× 981 0.3× 5.2k 1.8× 2.7k 1.1× 257 18.6k
Zi‐Jiang Chen China 59 6.7k 0.5× 6.4k 0.6× 2.5k 0.8× 849 0.3× 4.6k 1.8× 605 15.2k
Basil C. Tarlatzis Greece 57 10.0k 0.7× 7.3k 0.6× 4.0k 1.2× 1.1k 0.4× 1.2k 0.5× 307 13.6k
Lourdes Ibáñez Spain 63 6.5k 0.4× 4.5k 0.4× 4.9k 1.5× 4.6k 1.6× 2.8k 1.1× 325 14.7k
Rogerio A. Løbo United States 79 9.9k 0.7× 6.8k 0.6× 1.3k 0.4× 8.0k 2.8× 2.6k 1.0× 371 19.7k

Countries citing papers authored by Joop S.E. Laven

Since Specialization
Citations

This map shows the geographic impact of Joop S.E. Laven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joop S.E. Laven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joop S.E. Laven more than expected).

Fields of papers citing papers by Joop S.E. Laven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joop S.E. Laven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joop S.E. Laven. The network helps show where Joop S.E. Laven may publish in the future.

Co-authorship network of co-authors of Joop S.E. Laven

This figure shows the co-authorship network connecting the top 25 collaborators of Joop S.E. Laven. A scholar is included among the top collaborators of Joop S.E. Laven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joop S.E. Laven. Joop S.E. Laven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Laven, Joop S.E.. (2025). Polycystic ovary syndrome: antimüllerian hormone and its role in the pathophysiology of the syndrome. Fertility and Sterility. 124(5). 910–918.
2.
Barbagallo, Federica, et al.. (2024). The additional value of ultrasound markers in the diagnosis of polycystic ovary syndrome. Fertility and Sterility. 123(2). 342–349. 3 indexed citations
3.
Pastoor, Hester, Aya Mousa, Wichor M. Bramer, et al.. (2024). Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update. 30(3). 323–340. 9 indexed citations
4.
Koster, Maria P. H., Birgitta K. Velthuis, Ricardo P.J. Budde, et al.. (2023). Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome. Journal of Clinical Medicine. 12(16). 5226–5226. 6 indexed citations
5.
Cantineau, Astrid EP, Richard S. Legro, Ann Thurin‐Kjellberg, et al.. (2023). P-629 Dietary and/or physical activity interventions in women with overweight or obesity prior to fertility treatment – an individual participant data meta-analysis (Venus-IPD). Human Reproduction. 38(Supplement_1). 1 indexed citations
6.
Brewer, Kelly, Ryan Sisk, Hyejin Lee, et al.. (2023). OR20-02 Trans-Ethnic Analysis Of PCOS Subtype Genomewide Association Signals Reveals 3 Shared Subtype-Specific Loci. Journal of the Endocrine Society. 7(Supplement_1). 1 indexed citations
7.
8.
Al‐Hassany, Linda, Cindy Meun, Eric Boersma, et al.. (2023). Decreased role of neuropeptides in the microvascular function in migraine patients with polycystic ovary syndrome. Atherosclerosis. 384. 117172–117172. 6 indexed citations
9.
Teede, Helena, Chau Thien Tay, Joop S.E. Laven, et al.. (2023). Recommendations From the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Obstetrical & Gynecological Survey. 78(12). 742–743. 1 indexed citations
10.
Jiskoot, Geranne, et al.. (2022). Metabolic health during a randomized controlled lifestyle intervention in women with PCOS. EUR Research Repository (Erasmus University Rotterdam). 21 indexed citations
11.
Rousian, Melek, et al.. (2021). The influence of frozen-thawed and fresh embryo transfer on utero-placental (vascular) development: the Rotterdam Periconception cohort. Human Reproduction. 36(8). 2091–2100. 12 indexed citations
12.
Franasiak, Jason M., Diana Alecsandru, Eric J. Forman, et al.. (2021). A review of the pathophysiology of recurrent implantation failure. Fertility and Sterility. 116(6). 1436–1448. 123 indexed citations
13.
Hiam, Danielle, Alba Moreno‐Asso, Helena Teede, et al.. (2019). The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies. Journal of Clinical Medicine. 8(10). 1606–1606. 76 indexed citations
14.
Teede, Helena, Marie Misso, Eliza C. Tassone, et al.. (2019). Anti-Müllerian Hormone in PCOS: A Review Informing International Guidelines. Trends in Endocrinology and Metabolism. 30(7). 467–478. 137 indexed citations
15.
Kooi, Anne-Lotte van der, Marry M. van den Heuvel‐Eibrink, Sjoerd A.A. van den Berg, et al.. (2019). Changes in Anti-Müllerian Hormone and Inhibin B in Children Treated for Cancer. Journal of Adolescent and Young Adult Oncology. 8(3). 281–290. 11 indexed citations
16.
Krul-Poel, Yvonne H M, Régine P.M. Steegers‐Theunissen, Edwin ten Boekel, et al.. (2018). Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study. PLoS ONE. 13(12). e0204748–e0204748. 53 indexed citations
17.
Glišić, Marija, Blerim Mujaj, Oscar L. Rueda‐Ochoa, et al.. (2017). Associations of Endogenous Estradiol and Testosterone Levels With Plaque Composition and Risk of Stroke in Subjects With Carotid Atherosclerosis. Circulation Research. 122(1). 97–105. 39 indexed citations
18.
Dijk, Matthijs R. van, et al.. (2017). The use of the mHealth program Smarter Pregnancy in preconception care: rationale, study design and data collection of a randomized controlled trial. BMC Pregnancy and Childbirth. 17(1). 46–46. 42 indexed citations
19.
Fong, Sharon Lie, Jenny A. Visser, Corrine K. Welt, et al.. (2012). Serum Anti-Müllerian Hormone Levels in Healthy Females: A Nomogram Ranging from Infancy to Adulthood. The Journal of Clinical Endocrinology & Metabolism. 97(12). 4650–4655. 190 indexed citations
20.
Broekmans, F. J., Marinus J.C. Eijkemans, Ben J Cohlen, et al.. (2012). Does initiation of GnRH antagonists on cycle day 2 result in a more favourable follicular phase endocrine profile compared to initiation on cycle day 6. Human Reproduction. 27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Franks Breakdown of academic impact, for papers by Bart C.J.M. Fauser Breakdown of academic impact, for papers by Richard S. Legro Breakdown of academic impact, for papers by Ricardo Azziz Breakdown of academic impact, for papers by Andrea Dunaif Breakdown of academic impact, for papers by Héctor F. Escobar‐Morreale Breakdown of academic impact, for papers by Zi‐Jiang Chen Breakdown of academic impact, for papers by Basil C. Tarlatzis Breakdown of academic impact, for papers by Lourdes Ibáñez Breakdown of academic impact, for papers by Rogerio A. Løbo
Rankless by CCL
2026